EC Healthcare provided earnings guidance for the six months ended 30 September 2023. For the period, the company expects a decrease of not more than 80% in profit after tax ("Net Profit") for the Reporting Period as compared with the Net Profit of approximately HKD 105.2 million for the corresponding period ended 30 September 2022. However, if comparing to the second half of financial year ended 31 March 2023, it is expected that the financial results of the Group may record: an increase of not less than 1,000% in Net Profit for the Reporting Period as compared with the Net Profit of approximately HKD 1.8 million for six months ended 31 March 2023.

The Board believes that such year-on-year decrease in Net Profit during the Reporting Period was mainly attributable to: the decrease of approximately HKD 43.4 million in subsidies from Hong Kong Government under the Employment Support Scheme; temporary low operation leverage of the newly established service points from the previous financial year ended 31 March 2023; the increase in depreciation and amortization expenses incurred from the organic expansion during the previous financial year ended 31 March 2023; and the increase in interest expenses from bank borrowings of approximately HKD 17.0 million due the increasing interest rate.